Teemu Maaniitty

Country flagFinland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (15)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Aims Conflicting results have been reported on the prognostic value of coronary stenosis grade and plaque burden. We aimed to investigate the time-varying risk for cardiovascular events associated with diameter stenosis (DS%) and plaque burden. Methods and results Patients without a documented cardiac history who underwent coronary computed tomography angiography for suspected coronary artery disease were included. The most severe DS% and plaque burden, defined as percentage atheroma volume (PAV), were used for analysis. The primary endpoint was a composite of all-cause mortality and non-fatal myocardial infarction. For analysis, the maximal follow-up time was 8 years. Among 2819 patients [mean age 62 ± 10; 1245 (45%) male], 235 events occurred during a median follow-up of 6.9 years. Cox models including cardiovascular risk factors, DS%, and PAV demonstrated that DS% but not PAV was predictive for short-term events at 1-year follow-up [adjusted hazard ratio (aHR) 1.028, 95% confidence interval (CI) 1.013–1.044 vs. 1.015, 95% CI 0.978–1.053]. In contrast, PAV but not DS% was predictive for long-term events at 8-year follow-up (aHR 1.035, 95% CI 1.021–1.050 vs. 1.005, 95% CI 0.999–1.012). The predictive value of DS% was stronger before than after 1 year of follow-up (aHR <1 year 1.027, 95% CI 1.012–1.042 vs. aHR 1–8 years 1.001, 95% CI 0.994–1.008; P < 0.01 for difference), while the predictive value of PAV did not significantly change (P = 0.12). Conclusion Coronary diameter stenosis holds the highest prognostic significance for short-term cardiovascular events, while plaque burden predicts events in the long term.

Year:

2026

Aims The diagnostic performance of quantitative perfusion cardiac magnetic resonance (QP-CMR) imaging has scarcely been evaluated in patients with a history of coronary artery disease (CAD) and new onset chest pain. The present study compared the diagnostic performance of automated QP-CMR for the detection of fractional flow reserve (FFR) defined hemodynamically significant CAD with visual assessment of first-pass stress perfusion CMR (v-CMR) and quantitative [15O]H2O positron emission tomography (PET) imaging in a true head-to-head fashion in patients with prior CAD. Methods and results This PACIFIC-2 substudy included 145 symptomatic chronic coronary symptom patients with prior myocardial infarction and/or percutaneous coronary intervention. All patients underwent dual-sequence, single-bolus perfusion CMR, and [15O]H2O PET perfusion imaging followed by invasive coronary angiography with three-vessel FFR. Hemodynamically significant CAD was defined as an FFR ≤ 0.80. QP-CMR, v-CMR, and PET exhibited a sensitivity of 66, 67, and 80%, respectively, whereas specificity was 60, 62, and 63%. Sensitivity of QP-CMR was lower than that of PET (P = 0.015), whereas the specificity of QP-CMR and PET was comparable. Diagnostic accuracy and area under the curve of QP-CMR (64% and 0.66) was comparable to both v-CMR [66% (P = not significant [NS]) and 0.67 (P = NS)] and PET [74% (P = NS) and 0.78 (P = NS)]. Conclusion In patients with prior myocardial infarction and/or percutaneous coronary intervention, the diagnostic performance of QP-CMR was comparable to visual assessment of first-pass stress perfusion CMR and quantitative [15O]H2O PET for the detection of hemodynamically significant CAD as defined by FFR.

Year:

2025

Year:

2025

Background Artificial intelligence–guided quantitative computed tomography ischemia (AI‐QCT ischemia ) is a novel machine‐learning method for predicting myocardial ischemia from coronary computed tomography angiography (CCTA). This observational cohort study aimed to compare the long‐term prognostic value of AI‐QCT ischemia with hybrid CCTA/positron emission tomography (PET) myocardial perfusion imaging in suspected coronary artery disease (CAD). Methods Symptomatic patients with suspected CAD underwent CCTA with selective downstream PET to detect ischemic CAD. Blinded reanalysis of CCTA images was done using the AI‐QCT ischemia algorithm, providing a binary result (normal versus abnormal). Results In the full analysis set (n=2271), hybrid CCTA/PET imaging was successful in 94% of the patients and AI‐QCT ischemia evaluation was feasible in 83%, resulting in a per‐protocol set of 1772 patients (19% with ischemic CAD on hybrid CCTA/PET and 25% with abnormal AI‐QCT ischemia ). There was moderate‐to‐substantial agreement between the methods (Cohen’s κ=0.61). During a median follow‐up of 7.0 years, 177 (10%) patients experienced the composite end point of all‐cause death, myocardial infarction, or unstable angina. Ischemic CAD on hybrid CCTA/PET was predictive of the composite end point (hazard ratio [HR], 2.35 [95% CI, 1.62–3.40]; P <0.001), after adjustment for clinical variables and early (6‐month) myocardial revascularization. Similarly, an abnormal (ischemic) AI‐QCT ischemia result was independently predictive of adverse outcomes (adjusted HR, 1.98 [95% CI, 1.39–2.80]; P <0.001). The adjusted models, including either hybrid CCTA/PET or AI‐QCT ischemia , demonstrated similar discriminative ability (C‐index 0.734 versus 0.729; P =0.53). Conclusions The AI‐QCT ischemia algorithm demonstrated long‐term prognostic value comparable to hybrid CCTA/PET perfusion imaging in suspected CAD.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Collaborators (14)

Jelmer Westra

Aarhus University

DENMARK
View details

Mark Lubberink

Professor

Uppsala University

SWEDEN
View details

Simon Winther

VIP, Clinical Professor

Aarhus University

DENMARK
View details

Lars Christian Gormsen

VIP, Clinical Professor and Chair

Aarhus University

DENMARK
View details

Eike Nagel

Director

Goethe University Frankfurt

GERMANY
View details

Sarah Bär

University of Turku

FINLAND
View details

Pim van der Harst

Head of Department of Cardiology

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Antti Saraste

University of Turku

FINLAND
View details

Laust Dupont Rasmussen

MD, PhD

Aalborg University Hospital

DENMARK
View details

Sonia Borodzicz-Jażdżyk

Medical University of Warsaw

POLAND
View details

Morten Bøttcher

VIP, Clinical Professor

Aarhus University

DENMARK
View details

Jeroen J. Bax

Leiden University Medical Center

NETHERLANDS
View details

Takeru Nabeta

Assistant Professor

Kitasato University School of Medicine

JAPAN
View details

Juhani Knuuti

-

FINLAND
View details